Quantitative analysis of [18F]FDDNP PET using subcortical white matter as reference region

Koon-Pong Wong, Mirwais Wardak, Weber Shao, Magnus Dahlbom, Vladimir Kepe, Jie Liu, Nagichettiar Satyamurthy, Gary W Small, Jorge R Barrio, Sung-Cheng Huang, Koon-Pong Wong, Mirwais Wardak, Weber Shao, Magnus Dahlbom, Vladimir Kepe, Jie Liu, Nagichettiar Satyamurthy, Gary W Small, Jorge R Barrio, Sung-Cheng Huang

Abstract

Purpose: Subcortical white matter is known to be relatively unaffected by amyloid deposition in Alzheimer's disease (AD). We investigated the use of subcortical white matter as a reference region to quantify [(18)F]FDDNP binding in the human brain.

Methods: Dynamic [(18)F]FDDNP PET studies were performed on 7 control subjects and 12 AD patients. Population efflux rate constants (k(')(2)) from subcortical white matter (centrum semiovale) and cerebellar cortex were derived by a simplified reference tissue modeling approach incorporating physiological constraints. Regional distribution volume ratio (DVR) estimates were derived using Logan and simplified reference tissue approaches, with either subcortical white matter or cerebellum as reference input. Discriminant analysis with cross-validation was performed to classify control subjects and AD patients.

Results: The population estimates of k(')(2) in subcortical white matter did not differ significantly between control subjects and AD patients but the variability of individual estimates of k(')(2) determined in white matter was lower than that in cerebellum. Logan DVR showed dependence on the efflux rate constant in white matter. The DVR estimates in the frontal, parietal, posterior cingulate, and temporal cortices were significantly higher in the AD group (p<0.01). Incorporating all these regional DVR estimates as predictor variables in discriminant analysis yielded accurate classification of control subjects and AD patients with high sensitivity and specificity, and the results agreed well with those using the cerebellum as the reference region.

Conclusion: Subcortical white matter can be used as a reference region for quantitative analysis of [(18)F]FDDNP with the Logan method which allows more accurate and less biased binding estimates, but a population efflux rate constant has to be determined a priori.

Figures

Fig. 1
Fig. 1
Representative tissue TACs of a control subject (a) and an AD patient (d), and their ratios to the cerebellum (b, e) and white matter (c, f) (FRT frontal, PAR parietal, MTL medial temporal, LTL lateral temporal, PCG posterior cingulate, CBL cerebellum, SWM subcortical white matter)
Fig. 2
Fig. 2
Correlations between estimates of relative perfusion (to the reference region) using the summed image data (Rp) within the first 6 min after injection of [18F]FDDNP, and perfusion (relative to the reference region) obtained by SRTM (R1) for various regions in control subjects and AD patients. The reference regions were white matter (a) and cerebellum (b). Regression lines are shown in gray (FRT frontal, PAR parietal, MTL medial temporal, LTL lateral temporal, PCG posterior cingulate)
Fig. 3
Fig. 3
Logan DVR plots on the frontal cortex for a control subject (a) and an AD patient (b) using the cerebellum (CBL) and the subcortical white matter (SWM) as reference region, respectively. The value of was 0.023 min−1 when SWM was used as the reference region and it was 0.091 min−1 for the control subject and 0.086 min−1 for the AD patient when CBL was used as the reference region. Note the similarity in DVR values derived using either reference region. The time point corresponding to the “pseudo” equilibrium (t*=25 min) is also shown
Fig. 4
Fig. 4
Logan DVR plot on the cerebellum using the subcortical white matter as reference region (a) and the subcortical white matter using the cerebellum as reference region (b) for the same subjects as shown in Fig. 3. The time point corresponding to the “pseudo” equilibrium (t*=25 min) is also shown
Fig. 5
Fig. 5
Representative parametric images of Logan DVR using 125 min of data (with t*=35 min) and white matter as reference input in a control subject (a) and an AD patient (b)
Fig. 6
Fig. 6
Scatter plots of regional [18F]FDDNP binding derived by the Logan method using white matter (a) and cerebellum (b) as reference regions. Long and short horizontal bars represent means and standard deviations, respectively. The p-values were calculated using a nonparametric Mann-Whitney rank-sum test (one-tailed)
Fig. 7
Fig. 7
Effect of varying t* on the stability of regional DVR values derived by the Logan method with subcortical white matter as reference region in control subjects and AD patients for each region (n=5) and each subject (n=7 control subjects, n=12 AD patients). Percentage differences in DVR values due to increasing t* from 15 min to 85 min were calculated using estimates obtained with t*=35 min as reference values and are shown for control subjects (a) and AD patients (c), and the corresponding variability is shown for control subjects (b) and AD patients (d)
Fig. 8
Fig. 8
Effect of total scan duration on the stability of regional DVR values derived by the Logan method with subcortical white matter as reference region in control subjects and AD patients for each region (n=5) and each subject (n=7 control subjects, n=12 AD patients). Regional DVR values derived with shorter datasets, expressed as a percentage difference from their reference values estimated with the complete datasets (125 min of data collection and t*=35 min) are shown for control subjects (a) and AD patients (c). The variability, expressed as %CV, is shown for control subjects (b) and AD patients (d)
Fig. 9
Fig. 9
Effect of variation in in white matter on the accuracy of DVRs derived by Logan graphical analysis in control subjects (a) and AD patients (b). Variations in DVR in the frontal region (FRT), parietal region (PAR), medial temporal region (MTL), lateral temporal region (LTL), and posterior cingulate (PCG) were determined using an assumed value of 0.023 min−1

References

    1. Small GW, Kepe V, Ercoli LM, Siddarth P, Bookheimer SY, Miller KJ, et al. PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med. 2006;355:2652–2663. doi: 10.1056/NEJMoa054625.
    1. Shin J, Lee S-Y, Kim S-H, Kim Y-B, Cho S-J. Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer’s disease. Neuroimage. 2008;43:236–244. doi: 10.1016/j.neuroimage.2008.07.022.
    1. Kepe V, Ghetti B, Farlow M, Bresjanac M, Miller K, Huang S-C, et al. PET of brain prion protein amyloid in Gerstmann-Sträussler-Scheinker disease. Brain Pathol. 2009
    1. Barrio JR, Huang S-C, Cole G, Satyamurthy N, Petric A, Phelps ME, et al. PET imaging of tangles and plaques in Alzheimer disease with a highly hydrophobic probe. J Labelled Comp Radiopharm. 1999;42:S194–S195.
    1. Agdeppa ED, Kepe V, Liu J, Flores-Torres S, Satyamurthy N, Petric A, et al. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for β-amyloid plaques in Alzheimer’s disease. J Neurosci. 2001;21:RC189(1–5).
    1. Wong K-P, Kepe V, Small GW, Satyamurthy N, Barrio JR, Huang S-C. Comparison of simplified methods for quantitative analysis of [18F]FDDNP PET data. IEEE Nuclear Science Symposium and Medical Imaging Conference Record. Honolulu, Hawaii; 2007. p. 3146–50.
    1. Yaqub M, Tolboom N, Van Berckel BN, Scheltens P, Lammertsma AA, Boellaard R. Simplified parametric methods for [18F]FDDNP studies. Neuroimage. 2009
    1. Yaqub M, Boellaard R, Van Berckel BNM, Tolboom N, Luurtsema G, Dijkstra AA, et al. Evaluation of tracer kinetic models for analysis of [18F]FDDNP studies. Mol Imaging Biol. 2009;11:322–333. doi: 10.1007/s11307-009-0208-1.
    1. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab. 1996;16:834–840. doi: 10.1097/00004647-199609000-00008.
    1. Joachim CL, Morris JH, Selkoe DJ. Diffuse senile plaques occur commonly in the cerebellum in Alzheimer’s disease. Am J Pathol. 1989;135:309–319.
    1. Yamaguchi H, Hirai S, Morimatsu M, Shoji M, Nakazato Y. Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated by β protein immunostain. Acta Neuropathol. 1989;77:314–319. doi: 10.1007/BF00687584.
    1. Masters CL, Gajdusek DC, Gibbs CJ. Creutzfeldt-Jakob disease virus isolation from the Gerstmann-Sträussler syndrome with an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies. Brain. 1981;104:559–588. doi: 10.1093/brain/104.3.559.
    1. Thal DR, Rüb U, Orantes M, Braak H. Phase of Aβ-deposition in the human brain and its relevance for the development of AD. Neurology. 2002;58:1791–1800.
    1. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiat Res. 1975;12:189–198. doi: 10.1016/0022-3956(75)90026-6.
    1. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology. 1984;34:939–944.
    1. Liu J, Kepe V, Žabjek A, Petric A, Padgett HC, Satyamurthy N, et al. High-yield, automated radiosynthesis of 2-(1-{6-[(2-[18F]fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile ([18F]FDDNP) ready for animal or human administration. Mol Imaging Biol. 2007;9:6–16. doi: 10.1007/s11307-006-0061-4.
    1. Wong K-P, Wardak M, Shao W, Zhou Z, Dahlbom M, Smid L, et al. Movement correction of [18F]FDDNP PET studies for brain amyloid imaging. IEEE Nuclear Science Symposium and Medical Imaging Conference Record. Honolulu, Hawaii; 2007. p. 3974–7.
    1. Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage. 1996;4:153–158. doi: 10.1006/nimg.1996.0066.
    1. Marquardt DW. An algorithm for least-squares estimation of nonlinear parameters. J Soc Indust Appl Math. 1963;11:431–441. doi: 10.1137/0111030.
    1. Wu Y, Carson RE. Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging. J Cereb Blood Flow Metab. 2002;22:1440–1452. doi: 10.1097/00004647-200212000-00004.
    1. Wong K-P, Feng D, Meikle SR, Fulham MJ. Simultaneous estimation of physiological parameters and the input function – in vivo PET data. IEEE Trans Inform Technol Biomed. 2001;5:67–76. doi: 10.1109/4233.908397.
    1. Huber PJ. Robust statistical procedures. 2. Philadelphia: Society for Industrial and Applied Mathematics; 1996.
    1. Anderson TW. An introduction to multivariate statistical analysis. 2. New York: Wiley; 1984.
    1. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239–259. doi: 10.1007/BF00308809.
    1. Price JL, Morris JC. Tangles and plaques in nondemented aging and “preclinical” Alzheimer’s disease. Ann Neurol. 1999;45:358–368. doi: 10.1002/1531-8249(199903)45:3<358::AID-ANA12>;2-X.
    1. Lammertsma AA, Bench CJ, Hume SP, Osman S, Gunn K, Brooks DJ, et al. Comparison of methods for analysis of clinical [11C]raclopride studies. J Cereb Blood Flow Metab. 1996;16:42–52. doi: 10.1097/00004647-199601000-00005.
    1. Lopresti BJ, Klunk WE, Mathis CA, Hoge JA, Ziolko SK, Lu X, et al. Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. J Nucl Med. 2005;46:1959–1972.
    1. Rowe CC, Ackerman U, Browne W, Mulligan R, Pike KL, O’Keefe G, et al. Imaging of amyloid β in Alzheimer’s disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism. Lancet Neurol. 2008;7:129–135. doi: 10.1016/S1474-4422(08)70001-2.
    1. Logan J, Volkow ND, Fowler JS, Wang G-J, Dewey SL, MacGregor RR, et al. Effects of blood flow on [11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data. J Cereb Blood Flow Metab. 1994;14:995–1010.
    1. Cunningham VJ, Lammertsma AA. Radioligand studies in brain: kinetic analysis of PET data. Med Chem Res. 1994;5:79–96.
    1. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer’s disease. Ann Neurol. 1997;42:85–94. doi: 10.1002/ana.410420114.
    1. Ishii K, Sasaki M, Yamaji S, Sakamoto S, Kitagaki H, Mori E. Paradoxical hippocampus perfusion in mild-to-moderate Alzheimer’s disease. J Nucl Med. 1998;39:293–298.
    1. Huang S-C, Barrio JR, Phelps ME. Neuroreceptor assay with positron emission tomography: equilibrium versus dynamic approaches. J Cereb Blood Flow Metab. 1986;6:515–21.

Source: PubMed

3
구독하다